Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 229,162 |
|
|||||
| News | - | ||||||
| Day High | 8.8102 | Low High |
|||||
| Day Low | 8.55 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| TScan Therapeutics Inc | TCRX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 0.35% | 8.65 | 15:26:35 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.76 | 8.55 | 8.8102 | 8.65 | 8.62 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,745 | 229,162 | US$ 8.69 | US$ 1,991,555 | - | 1.71 - 9.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:11 | formt | 100 | US$ 8.65 | USD |
TScan Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 414.18M | 47.88M | - | 21.05M | -89.22M | -1.86 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
TScan Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TCRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.4574 | 8.8102 | 7.035 | 7.87 | 191,599 | 1.19 | 15.99% |
| 1 Month | 7.20 | 8.8102 | 6.58 | 7.20 | 233,972 | 1.45 | 20.14% |
| 3 Months | 5.76 | 9.00 | 5.44 | 7.20 | 214,763 | 2.89 | 50.17% |
| 6 Months | 3.62 | 9.00 | 3.62 | 6.47 | 173,319 | 5.03 | 138.95% |
| 1 Year | 1.85 | 9.00 | 1.71 | 4.12 | 487,062 | 6.80 | 367.57% |
| 3 Years | 12.00 | 14.71 | 1.45 | 4.15 | 218,351 | -3.35 | -27.92% |
| 5 Years | 12.00 | 14.71 | 1.45 | 4.15 | 218,351 | -3.35 | -27.92% |
TScan Therapeutics Description
| TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. |
